Is It Possible to Predict Pre Term Labor by Measuring Cervical Length in the Non-pregnant Uterus?
NCT ID: NCT01340352
Last Updated: 2015-06-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
62 participants
OBSERVATIONAL
2011-05-31
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To investigate the association between cervical length in non-pregnant women, and the risk of premature birth.
The participants will be recruited from the HaEmek Medical Center delivery room registration. Women delivered between 24-37 pregnancy weeks will be allocated to the study group. The investigators will invite them 3 month or more after delivery to ultrasound examination of the cervical length. The participants in the control group will be the women whom term delivery follows by chronological manner to those in study group. Data of the cervucal length will be collected at the time of the examination.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preterm Labor Prediction by Cervical Contour in Ultrasound
NCT01912508
Cervical Volume and Prediction of Preterm Labor
NCT06190496
Cervical Volume by Three-Dimensional Ultrasound as a Predictor of Preterm Delivery
NCT00342550
The Use of Cervical Length to Reduce Hospital Stay in Women Admitted Because of Preterm Labor.
NCT00432250
Prediction of Preterm Delivery with Serial Cervical Length Measurements After Threatened Preterm Labor
NCT05044143
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Ultrasound examination will be performed using the Voluson E8 device, General Electric.
The cervical length,between the external and internal orifice will be measured using conventional technologies available including: Doppler, three dimensional and two dimensional ultrasound.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study group: previous preterm labor
No interventions assigned to this group
control group:previous term delivery
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Singelton last pregnancy.
* Last birth, spontaneous premature (24-37 week)
* Last birth at least 3 months ago.
Exclusion Criteria
* Sonographic pathologic findings.
* Technical failure (failed appropiate sonographic visualisation)
* Presence of fetal malformations ( in preterm delivery )
* Presence of comorbidities including diabetes, hypertension, collagen disease, thrombophilia
* Presence of risk factors for premature delivery (amniotic fluid infection,
* cervical surgical treatments - conization, polyhydramnios, etc.).
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
HaEmek Medical Center, Israel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Etty Spiegel
Director of Ultrasound Unit
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Etty Daniel-Spiegel, MD
Role: PRINCIPAL_INVESTIGATOR
haemek medical center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dep. OB/GYN, Emek Medical Center
Afula, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0137-10-EMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.